Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Class A common stock, $0.001 par value
-
Shares outstanding
-
162,690,355
-
Total 13F shares
-
155,587,802
-
Share change
-
-8,943,189
-
Total reported value
-
$228,692,691
-
Put/Call ratio
-
0.06%
-
Price per share
-
$1.47
-
Number of holders
-
200
-
Value change
-
-$26,001,186
-
Number of buys
-
101
-
Number of sells
-
114
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) as of Q1 2025
As of 31 Mar 2025,
IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) was held by
200 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
155,587,802 shares.
The largest 10 holders included
Sarissa Capital Management LP, VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, BRAIDWELL LP, MILLENNIUM MANAGEMENT LLC, Kynam Capital Management, LP, LSV ASSET MANAGEMENT, and JANE STREET GROUP, LLC.
This page lists
200
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.